Summary
Guardant Health, Inc. (GH) filed an 8-K on January 13, 2025, primarily to disclose preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2024. The press release containing these results is furnished as Exhibit 99.1, which investors should review for specific financial performance metrics. The company also indicated that a presentation for the 2025 J.P. Morgan Healthcare Conference, scheduled for the same date, would be made available on their investor relations website.
Key Highlights
- 1Guardant Health announced preliminary financial results for Q4 and full year 2024.
- 2The financial results are contained in a press release furnished as Exhibit 99.1.
- 3The company will present at the 2025 J.P. Morgan Healthcare Conference.
- 4A presentation from the J.P. Morgan Healthcare Conference will be posted on the company's investor website.
- 5Information furnished is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- 6The filing includes the Cover Page Interactive Data File as Exhibit 104.
Frequently Asked Questions
The main purpose of this 8-K filing is to announce Guardant Health's preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2024, through a press release furnished as an exhibit.
The detailed preliminary financial information is provided in the press release, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for specific financial data.
Yes, Guardant Health will be presenting at the 2025 J.P. Morgan Healthcare Conference on January 13, 2025. A presentation from this conference will be made available on the company's investor relations website.
No, the information furnished in this Current Report on Form 8-K, including Exhibit 99.1, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section, unless specifically incorporated by reference into another filing.